1381Accesses
85Citations
3Altmetric
Abstract
Non-infectious granulomatous diseases of the skin are a broad group of distinct reactive inflammatory conditions that share important similarities. As a group, they are relatively difficult to diagnose and distinguish both clinically as well as histologically. Many of these disorders have significant associations with systemic diseases that impact the patient’s overall prognosis. In this update, we offer a discussion of emerging concepts and controversies in this field, as presented through evidence-based answers to seven important clinical questions regarding palisading and epithelioid granulomata. These questions offer an opportunity to review ten non-infectious granulomatous conditions that have implications for systemic disease: granuloma annulare, annular elastolytic giant cell granuloma, necrobiosis lipoidica, methotrexate-induced accelerated rheumatoid nodulosis, necrobiotic xanthogranuloma, interstitial granulomatous dermatitis, interstitial granulomatous drug reaction, palisaded neutrophilic granulomatous dermatitis, sarcoidosis, and metastatic Crohn disease. Recent clinical, epidemiologic, and laboratory studies have shed some light on these diseases, the association of these conditions with systemic disorders, and their overall prognoses.
This is a preview of subscription content,log in via an institution to check access.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price includes VAT (Japan)
Instant access to the full article PDF.

Similar content being viewed by others
References
Rook GA, Stanford JL. Slow bacterial infections or autoimmunity? Immunol Today 1992 May; 13 (5): 160–4
Nikkels AF, Pierard GE. Are granulomatous reactions in old zoster lesions due to an immune response to varicella zoster virus envelope glucoproteins? Clin Exp Dermatol 1998 Sep; 23 (5): 237–8
Dzirlo L, Hubner M, Muller C, et al. A mimic of sarcoidosis [letter]. Lancet 2007 May 26; 369 (9575): 1832
Cribier B, Caille A, Heid E, et al. Erythema nodosum and associated diseases: a study of 129 cases. Int J Dermatol 1998 Sep; 37 (9): 667–72
Magro CM, Crowson AN. A distinctive cutaneous reaction pattern indicative of infection by reactive arthropathy-associated microbial pathogens: the superantigen ID reaction. J Cutan Pathol 1998 Nov; 25 (10): 538–44
Izikson L, English JC. Noninfectious granulomatous diseases: an update. Adv Dermatol 2006; 22: 31–53
James WD, Berger T, Elston D, editor. Andrews’ diseases of the skin: clinical dermatology. 10th ed. Philadelphia (PA): Elsevier Saunders, 2005
McKee PH, Calonje JE, Granter SR, editor. Pathology of the skin: with clinical correlations. 3rd ed. Philadelphia (PA): Mosby, 2005
Weedon D, editor. Skin pathology. 2nd ed. New York: Churchill Livingstone, 2002
Ball NJ, Kho GT, Martinka M. The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases. J Cutan Pathol 2004 Feb; 31 (2): 160–8
Li A, Hogan DJ, Sanusi ID, et al. Granuloma annulare and malignant neoplasms. Am J Dermatopathology 2003 Apr; 25 (2): 113–6
Abunasra H, Morgan E. Granuloma annulare and malignant neoplasms. Am J Dermatopathol 2003 Dec; 25 (6): 502–3
Shimizu S, Yasui C, Tsuchiya K. A typical generalized granuloma annulare associated with two visceral cancers. J Am Acad Dermatol 2006 May; 54 (5 Suppl.): S236–8
Dadban A, Slama B, Azzedine A, et al. Widespread granuloma annulare and Hodgkin’s disease. Clin Exp Dermatol 2008 Jul; 33 (4): 465–8
Hinckley MR, Walsh SN, Molnar I, et al. Generalized granuloma annulare as an initial manifestation of chronic myelomonocytic leukemia: a report of 2 cases. Am J Dermatopathol 2008 Jun; 30 (3): 274–7
Dahl MV. Granuloma annulare: long-term follow-up. Arch Dermatol 2007 Jul; 143 (7): 946–7
Barksdale SK, Perniciaro C, Halling KC, et al. Granuloma annulare in patients with malignant lymphoma: clinicopathologic study of thirteen new cases. J Am Acad Dermatol 1994 Jul; 31 (1): 42–8
Dabski K, Winkelmann RK. Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol 1989 Jan; 20 (1): 39–47
Swing Jr DC, Sheehan DJ, Sangueza OP, et al. Interstitial granulomatous dermatitis secondary to acute promyelocytic leukemia. Am J Dermatopathol 2008 Apr; 30 (2): 197–9
Cohen PR. Granuloma annulare, relapsing polychondritis, sarcoidosis, and systemic lupus erythematosus: conditions whose dermatologic manifestations may occur as hematologic malignancy-associated mucocutaneous paraneoplastic syndromes. Int J Dermatol 2006 Jan; 45 (1): 70–80
O’Brien JP, Regan W. Actinically degenerate elastic tissue is the likely antigenic basis of actinic granuloma of the skin and of temporal arteritis. J Am Acad Dermatol 1999 Feb; 40 (2 Pt 1): 214–22
Limas C. The spectrum of primary cutaneous elastolytic granulomas and their distinction from granuloma annulare: a clinicopathological analysis. Histopathology 2004 Mar; 44 (3): 277–82
Kuramoto Y, Watanabe M, Tagami H. Adult T cell leukemia accompanied by annular elastolytic giant cell granuloma. Acta Dermato-Venereologica 1990; 70 (2): 164–7
Garg A, Kundu RV, Plotkin O, et al. Annular elastolytic giant cell granuloma heralding onset and recurrence of acute myelogenous leukemia. Arch Dermatol 2006 Apr; 142 (4): 532–3
Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum: a clinical and pathological investigation of 171 cases. Arch Dermatol 1966 Mar; 93 (3): 272–81
O’Toole EA, Kennedy U, Nolan JJ, et al. Necrobiosis lipoidica: only aminority of patients have diabetes mellitus. Br J Dermatol 1999 Feb; 140 (2): 283–6
Kelly WF, Nicholas J, Adams J, et al. Necrobiosis lipoidica diabeticorum: association with background retinopathy, smoking, and proteinuria. A case controlled study. Diabet Med 1993 Oct; 10 (8): 725–8
Verrotti A, Chiarelli F, Amerio P, et al. Necrobiosis lipoidica diabeticorum in children and adolescents: a clue for underlying renal and retinal disease. Pediatr Dermatol 1995 Sep; 12 (3): 220–3
Pavlovic MD, Milenkovic T, Dinic M, et al. The prevalence of cutaneous manifestations in young patients with type 1 diabetes. Diabetes Care 2007 Aug; 30 (8): 1964–7
Findlay GH, Morrison JG, de Beer HA. Non-diabetic necrobiosis lipoidica: hitherto unrecognized papulonecrotic, nodulo-ulcerative and familial forms of the disease. South Afr Med J 1981 Mar 7; 59 (10): 323–6
Ho KK, O’Loughlin S, Powell FC. Familial non-diabetic necrobiosis lipoidica. Aust J Dermatol 1992; 33 (1): 31–4
Roche-Gamon E, Vilata-Corell JJ, Velasco-Pastor M. Familial necrobiosis lipoidica not associated with diabetes. Dermatol Online J 2007 Jul; 13 (3): 26
Shimanovich I, Erdmann H, Grabbe J, et al. Necrobiosis lipoidica in monozygotic twins. Arch Dermatol 2008 Jan; 144 (1): 119–20
Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in longterm therapy for rheumatoid arthritis. Arthritis Rheum 1986 Jul; 29 (7): 822–31
Kerstens PJ, Boerbooms AM, Jeurissen ME, et al. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis: an analysis of ten cases. J Rheumatol 1992 Jun; 19 (6): 867–71
Muzaffer MA, Schneider R, Cameron BJ, et al. Accelerated nodulosis during methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr 1996 May; 128 (5 Pt 1): 698–700
Ahmed SS, Arnett FC, Smith CA, et al. The HLA-DRB1*0401 allele and the development of methotrexate-induced accelerated rheumatoid nodulosis: a follow-up study of 79 Caucasian patients with rheumatoid arthritis. Medicine 2001 Jul; 80 (4): 271–8
Sayah A, English 3rd JC. Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol 2005 Aug; 53 (2): 191–209; quiz 10-2
Cunnane G, Warnock M, Fye KH, et al. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum 2002 Aug; 47 (4): 445–9
Mackley CL, Ostrov BE, Ioffreda MD. Accelerated cutaneous nodulosis during infliximab therapy in a patient with rheumatoid arthritis. J Clin Rheumatol 2004 Dec; 10 (6): 336–8
Langevitz P, Maguire L, Urowitz M. Accelerated nodulosis during azathioprine therapy. Arthritis Rheum 1991 Jan; 34 (1): 123–4
Berkun Y, Abou Atta I, Rubinow A, et al. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis. J Rheumatol 2007 Aug; 34 (8): 1664–9
Al-Bermani A, Figueiredo F, Speight EL, et al. Necrobiotic xanthogranuloma masquerading as posterior scleritis. Eye 2009 Jan; 23 (1): 239–40
Ugurlu S, Bartley GB, Gibson LE. Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement. Am J Ophthalmol 2000 May; 129 (5): 651–7
Bullock JD, Bartley GB, Campbell RJ, et al. Necrobiotic xanthogranuloma with paraproteinemia: case report and a pathogenetic theory. Trans Am Ophthalmol Soc 1986; 84: 342–54
Zelger B, Eisendle K, Mensing C, et al. Detection of spirochetal microorganisms by focus-floating microscopy in necrobiotic xanthogranuloma. J Am Acad Dermatol 2007 Dec; 57 (6): 1026–30
Fortson JS, Schroeter AL. Necrobiotic xanthogranuloma with IgA paraproteinemia and extracutaneous involvement. Am J Dermatopathology 1990 Dec; 12 (6): 579–84
Chave TA, Hutchinson PE. Necrobiotic xanthogranuloma with two monoclonal paraproteins and no periorbital involvement at presentation. Clin Exp Dermatol 2001 Sep; 26 (6): 493–6
Martinez Fernandez M, Rodriguez Prieto MA, Ruiz Gonzalez I, et al. Necrobiotic xanthogranuloma associated with myeloma. J Eur Acad Dermatol Venereol 2004 May; 18 (3): 328–31
Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. New Engl J Med 2002 Feb 21; 346 (8): 564–9
Mehregan DA, Winkelmann RK. Necrobiotic xanthogranuloma. Arch Dermatol 1992 Jan; 128 (1): 94–100
Venencie PY, Puissant A, Verola O, et al. Necrobiotic xanthogranuloma with myeloma: a case report. Cancer 1987 Feb 1; 59 (3): 588–92
Lynch JM, Barrett TL. Collagenolytic (necrobiotic) granulomas: part II. The ‘red’ granulomas. J Cutan Pathol 2004 Jul; 31 (6): 409–18
Winkelmann RK, Litzow MR, Umbert IJ, et al. Giant cell granulomatous pulmonary and myocardial lesions in necrobiotic xanthogranuloma with paraproteinemia. Mayo Clinic Proc 1997 Nov; 72 (11): 1028–33
Dykman CJ, Galens GJ, Good AE. Linear subcutaneous bands in rheumatoid arthritis: an unusual form of rheumatoid granuloma. Ann Intern Med 1965 Jul; 63: 134–40
Finan MC, Winkelmann RK. The cutaneous extravascular necrotizing granuloma (Churg-Strauss granuloma) and systemic disease: a review of 27 cases. Medicine 1983 May; 62 (3): 142–58
Chu P, Connolly MK, LeBoit PE. The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol 1994 Oct; 130 (10): 1278–83
Sangueza OP, Caudell MD, Mengesha YM, et al. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol 2002 Aug; 47 (2): 251–7
Panayi GS. Does rheumatoid arthritis have a clinicopathological spectrum similar to that of leprosy? Ann Rheum Dis 1982 Feb; 41 (1): 102–3
Asahina A, Fujita H, Fukunaga Y, et al. Early lesion of palisaded neutrophilic granulomatous dermatitis in ulcerative colitis. Eur J Dermatol 2007 May-Jun; 17 (3): 234–7
Biswas A, Chittari K, Gey van Pittius D, et al. Palisaded neutrophilic and granulomatous dermatitis in a child with type I diabetes mellitus and coeliac disease. Br J Dermatol 2008 Aug; 159 (2): 488–9
Bremner R, Simpson E, White CR, et al. Palisaded neutrophilic and granulomatous dermatitis: an unusual cutaneous manifestation of immunemediated disorders. Semin Arthritis Rheum 2004 Dec; 34 (3): 610–6
Germanas JP, Mehrabi D, Carder KR. Palisaded neutrophilic granulomatous dermatitis in a 12-year-old girl with systemic lupus erythematosus. J Am Acad Dermatol 2006 Aug; 55 (2 Suppl.): S60–2
Hantash BM, Chiang D, Kohler S, et al. Palisaded neutrophilic and granulomatous dermatitis associated with limited systemic sclerosis. J Am Acad Dermatol 2008 Apr; 58 (4): 661–4
Busquets-Perez N, Narvaez J, Valverde-Garcia J. Interstitial granulomatous dermatitis with arthritis (Ackerman syndrome). J Rheumatol 2006 Jun; 33 (6): 1207–9
Lee HW, Chang SE, Lee MW, et al. Interstitial granulomatous dermatitis with plaques associated with antiphospholipid syndrome. Br J Dermatol 2005 Apr; 152 (4): 814–6
Lee KJ, Lee ES, Lee DY, et al. Interstitial granulomatous dermatitis associated with autoimmune hepatitis. J Eur Acad Dermatol Venereol 2007 May; 21 (5): 684–5
Verneuil L, Dompmartin A, Comoz F, et al. Interstitial granulomatous dermatitis with cutaneous cords and arthritis: a disorder associated with autoantibodies. J Am Acad Dermatol 2001 Aug; 45 (2): 286–91
Deng A, Harvey V, Sina B, et al. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Arch Dermatol 2006 Feb; 142 (2): 198–202
Perrin C, Lacour JP, Michiels JF. Interstitial granulomatous drug reaction with a histological pattern of interstitial granulomatous dermatitis. Am J Dermatopathol 2001 Aug; 23 (4): 295–8
Dyson SW, Hirsch A, Jaworsky C. Interstitial granulomatous dermatitis secondary to soy. J Am Acad Dermatol 2004 Aug; 51 (2 Suppl.): S105–7
Magro CM, Crowson AN, Schapiro BL. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol 1998 Feb; 25 (2): 72–8
Chen YC, Hsiao CH, Tsai TF. Interstitial granulomatous drug reaction presenting as erythroderma: remission after discontinuation of enalapril maleate. Br J Dermatol 2008 May; 158 (5): 1143–5
Fujita Y, Shimizu T, Shimizu H. A case of interstitial granulomatous drug reaction due to sennoside. Br J Dermatol 2004 May; 150 (5): 1035–7
Marcollo Pini A, Kerl K, Kamarachev J, et al. Interstitial granulomatous drug reaction following intravenous ganciclovir. Br J Dermatol 2008 Jun; 158 (6): 1391–3
Groves C, McMenamin ME, Casey M, et al. Interstitial granulomatous reaction to strontium ranelate. Arch Dermatol 2008 Feb; 144 (2): 268–9
Lee HW, Yun WJ, Lee MW, et al. Interstitial granulomatous drug reaction caused by Chinese herbal medication. J Am Acad Dermatol 2005 Apr; 52 (4): 712–3
English 3rd JC, Patel PJ, Greer KE. Sarcoidosis. J Am Acad Dermatol 2001 May; 44 (5): 725–43; quiz 44-6
Tchernev G. Cutaneous sarcoidosis: the “great imitator”: etiopathogenesis, morphology, differential diagnosis, and clinical management. Am J Clin Dermatol 2006; 7 (6): 375–82
Veien NK, Stahl D, Brodthagen H. Cutaneous sarcoidosis in Caucasians. J Am Acad Dermatol 1987 Mar; 16 (3 Pt 1): 534–40
Mana J, Marcoval J, Graells J, et al. Cutaneous involvement in sarcoidosis: relationship to systemic disease. Arch Dermatol 1997 Jul; 133 (7): 882–8
Yanardag H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 2003 Aug; 97 (8): 978–82
Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983 Autumn; 52 (208): 525–33
Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease? J Am Acad Dermatol 2006 Jan; 54 (1): 55–60
Neville E, Carstairs LS, James DG. Bone sarcoidosis. Ann NY Acad Sci 1976; 278: 475–87
Cohen PR, Kurzrock R. Sarcoidosis and malignancy. Clin Dermatol 2007 May-Jun; 25 (3): 326–33
Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer 1974 Mar; 29 (3): 247–51
Romer FK, Hommelgaard P, Schou G. Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients. Eur Respir J 1998 Oct; 12 (4): 906–12
Reich JM, Mullooly JP, Johnson RE. Linkage analysis of malignancy-associated sarcoidosis. Chest 1995 Mar; 107 (3): 605–13
Askling J, Grunewald J, Eklund A, et al. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999 Nov; 160 (5 Pt 1): 1668–72
Brincker H. Sarcoid reactions and sarcoidosis in Hodgkin’s disease and other malignant lymphomata. Br J Cancer 1972 Apr; 26 (2): 120–3
Brincker H. Sarcoidosis and malignancy. Chest 1995 Nov; 108 (5): 1472–4
Merchant TE, Filippa DA, Yahalom J. Sarcoidosis following chemotherapy for Hodgkin’s disease. Leuk Lymphoma 1994 Apr; 13 (3-4): 339–47
Sawhney M, Sharma YK, Gera V, et al. Ichthyosiform sarcoidosis following chemotherapy of Hodgkin’s disease. Indian J Dermatol Venereol Leprol 2003 May-Jun; 69 (3): 220–2
Sacks EL, Donaldson SS, Gordon J, et al. Epithelioid granulomas associated with Hodgkin’s disease: clinical correlations in 55 previously untreated patients. Cancer 1978 Feb; 41 (2): 562–7
Ploysangam T, Heubi JE, Eisen D, et al. Cutaneous Crohn’s disease in children. J Am Acad Dermatol 1997 May; 36 (5 Pt 1): 697–704
Slater DN, Waller PC, Reilly G. Cutaneous granulomatous vasculitis: presenting feature of Crohn’s disease. J Royal Soc Medi 1985 Jul; 78 (7): 589–90
Murphy MJ, Kogan B, Carlson JA. Granulomatous lymphangitis of the scrotum and penis: report of a case and review of the literature of genital swelling with sarcoidal granulomatous inflammation. J Cutan Pathol 2001 Sep; 28 (8): 419–24
Burgdorf W. Cutaneous manifestations of Crohn’s disease. J Am Acad Dermatol 1981 Dec; 5 (6): 689–95
Shum DT, Guenther L. Metastatic Crohn’s disease: case report and review of the literature. Arch Dermatol 1990 May; 126 (5): 645–8
Palamaras I, El-Jabbour J, Pietropaolo N, et al. Metastatic Crohn’s disease: a review. J Eur Acad Dermatol Venereol 2008 Sept; 22 (9): 1033–43
Crowson AN, Nuovo GJ, Mihm Jr MC, et al. Cutaneous manifestations of Crohn’s disease, its spectrum, and its pathogenesis: intracellular consensus bacterial 16S rRNA is associated with the gastrointestinal but not the cutaneous manifestations of Crohn’s disease. Hum Pathol 2003 Nov; 34 (11): 1185–92
Hoque SR, Mortimer P, Cliff S. Penile and scrotal swelling in a child. Clin Exp Dermatol 2005 Nov; 30 (6): 727–8
Mooney EE, Walker J, Hourihane DO. Relation of granulomas to lymphatic vessels in Crohn’s disease. J Clin Pathol 1995 Apr; 48 (4): 335–8
Cockburn AG, Krolikowski J, Balogh K, et al. Crohn disease of penile and scrotal skin. Urology 1980 Jun; 15 (6): 596–8
Guest GD, Fink RL. Metastatic Crohn’s disease: case report of an unusual variant and review of the literature. Dis Colon Rectum 2000 Dec; 43 (12): 1764–6
Talansky AL, Meyers S, Greenstein AJ, et al. Does intestinal resection heal the pyoderma gangrenosum of inflammatory bowel disease? J Clin Gastroenterol 1983 Jun; 5 (3): 207–10
Acknowledgments
No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Department of Dermatology, University of Pittsburgh, School of Medicine University of Pittsburgh Medical Center, 200 Lothrop St., Presby South Tower, Suite 3825, Pittsburgh, Pennsylvania, 15213, USA
Elena Balestreire Hawryluk, Leonid Izikson & Joseph C. English III MD (Assoc. Prof. of Dermatology, Clinical Vice-Chairman for Quality and Innovation)
- Elena Balestreire Hawryluk
You can also search for this author inPubMed Google Scholar
- Leonid Izikson
You can also search for this author inPubMed Google Scholar
- Joseph C. English III MD
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toJoseph C. English III MD.
Rights and permissions
About this article
Cite this article
Hawryluk, E.B., Izikson, L. & English, J.C. Non-Infectious Granulomatous Diseases of the Skin and their Associated Systemic Diseases.Am J Clin Dermatol11, 171–181 (2010). https://doi.org/10.2165/11530080-000000000-00000
Published:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative